Recently, well-known Japanese pharmaceutical company Kobayashi Pharmaceuticals stated that some consumers who have taken the company's health products containing red yeast have recently experienced symptoms caused by kidney disease and other illnesses. In view of this situation, the company has decided to recall three products containing relevant ingredients. On the 22nd, Xiaolin Pharmaceutical announced on its official website that some consumers who take the company's health products containing red yeast have recently experienced symptoms such as kidney disease. According to Japanese media reports, since January this year, 13 reports of physical discomfort have been received from consumers, including 6 hospitalized for treatment, and some patients even need dialysis. Kobayashi Pharmaceuticals stated that after conducting ingredient analysis on its red yeast health products, it was found that some of the red yeast raw materials may contain unknown ingredients beyond the company's control. At present, there is no consensus on whether this unknown ingredient is related to consumer illness. However, in order to prevent further damage to consumer health, Xiaolin Pharmaceutical has decided to recall three products containing red yeast and called on consumers to immediately stop taking these three products. According to Japanese media reports, the number of recalls has reached about 300000. On the evening of the 22nd, the president of Xiaolin Pharmaceutical held a press conference and apologized by bowing to this issue. According to Japanese media reports, the analysis results on the 16th of this month showed that it may contain unknown ingredients, but the company did not announce a recall until the 22nd. In response, the president of Xiaolin Pharmaceutical admitted to delayed decision-making. Kobayashi Pharmaceuticals is a well-established Japanese pharmaceutical company with over 100 years of history. The company's regular medicines such as liquid band aids and children's antipyretic patches have also gained some popularity among tourists visiting Japan. The relevant health products recalled this time have been sold in many cosmetics stores in Japan before, so it is not ruled out that some tourists visiting Japan may purchase the relevant products. In addition, some domestic e-commerce websites in China are still selling related products. We remind consumers who have purchased similar health products to confirm as soon as possible and immediately stop taking the products that the manufacturer has announced a recall. (Lai Xin She)